HOME >> BIOLOGY >> NEWS
M. D. Anderson team identifies new oncogene for brain cancer

HOUSTON -- An overexpressed gene found at the scene of a variety of tumors is implicated in the development of two types of malignant brain cancer in a paper by researchers at The University of Texas M. D. Anderson Cancer Center to be published in the Proceedings of the National Academy of Sciences. The paper will be posted online at the PNAS web site the week of July 2.

Just because a gene is associated with cancer doesnt mean that its actually causing cancer. In this paper we show for the first time that insulin-like growth factor binding protein 2 (IGFBP2) connects with two other proteins to fuel development and progression of brain tumors, says senior author Wei Zhang, Ph.D., professor in M. D. Andersons Department of Pathology.

Using a gene transfer delivery system in a mouse model, a team led by Zhang and Professor of Pathology Gregory Fuller, M.D., Ph.D., shows that IGFBP2 plays an active role in the tumorigenesis of astrocytoma and oligodendroglioma. Both cancers are forms of glioma, cancers that develop in the glial cells which normally support and nourish neurons -- that are highly resistant to treatment.

This makes IGFBP2 an important candidate for development of targeted therapy to treat gliomas, Zhang says. Gliomas kill about 13,000 people in the United States annually.

The possibilities are not limited to brain cancer, Fuller notes, because of the pervasive overexpression of IGFBP2 documented in other cancer types. The gene is expressed only at low levels in normal cells, which would potentially reduce side effects caused by a treatment that targeted the gene or its protein product.

Fuller and Zhang first associated overexpression of the gene with brain cancer in 1999. Other researchers have since found it to be overexpressed in prostate, ovarian, breast and colorectal cancers, some leukemias, and also in drug-resistant tumors.

Overabundance of IGFBP2 has since been shown to be a
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
2-Jul-2007


Page: 1 2 3

Related biology news :

1. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
2. U-M team identifies gene that regulates blood-forming fetal stem cells
3. Study identifies new gene therapy tools for inherited blindness
4. Study identifies energy efficiency as reason for evolution of upright walking
5. Study identifies a common genetic risk factor for colorectal and prostate cancer
6. Weill Cornell team identifies potential new cancer drug target
7. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
8. 454 sequencing identifies HIV drug resistance at early stage
9. Ultra deep sequencing identifies HIV drug resistance at early stage
10. Research team identifies new Alzheimers gene
11. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2019)... IRVINE, Calif. (PRWEB) , ... June 27, 2019 , ... ... from the Illuminating Energy Society (IES), which honored the designers for creating both engaging ... area of 701B Street , an office tower in San Diego, California earned ...
(Date:6/19/2019)... ... June 19, 2019 , ... Dahryn Trivedi, today released research results ... Sodium, antibiotic which can prove to be beneficial for treating multiple bacterial diseases. , ... amount , Over 68% decrease in weight , Over ...
(Date:6/14/2019)... ... , ... Molecular diagnostics segment is the fastest-growing segment within the global IVD ... segments that are expected to drive the growth are infectious diseases, cancer, and transplant ... Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The discovery of ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... , ... June 26, 2019 , ... Alice Branton today ... on improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for ... alteration of characteristic differentiation peak, change in crystallite size , Over 142% ...
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... ... of its distribution network with the appointment of Biofeedback Tech Ltd ... monitoring systems are an essential part of many therapeutic treatments and clinical assessment ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 11, 2019 , ... ... company of Personalized Stem Cells Inc. (PSC) , has announced that their ... Public Health, Food and Drug Branch for manufacturing. This is an important ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
Breaking Biology Technology:
Cached News: